Citation Impact
Citing Papers
Requirement of bic/microRNA-155 for Normal Immune Function
2007 StandoutScience
MicroRNA-155 is induced during the macrophage inflammatory response
2007 StandoutNobel
Circulating microRNAs as stable blood-based markers for cancer detection
2008 Standout
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Acromegaly
2006 Standout
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
Eukaryotic regulatory RNAs: an answer to the ‘genome complexity’ conundrum
2007
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
2015 Standout
Targeting microRNAs in cancer: rationale, strategies and challenges
2010
The Nuclear-Retained Noncoding RNA MALAT1 Regulates Alternative Splicing by Modulating SR Splicing Factor Phosphorylation
2010 Standout
MicroRNA sponges: Progress and possibilities
2010
Potent effect of target structure on microRNA function
2007 StandoutNobel
MicroRNA‐183 family conservation and ciliated neurosensory organ expression
2008 StandoutNobel
TRBP alters human precursor microRNA processing in vitro
2012 StandoutNobel
A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients
2004
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
2011 Standout
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment
2016
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
miRBase: tools for microRNA genomics
2007 Standout
Epigenetics in Cancer
2008 Standout
Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors
2007
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell
2009
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
2007 StandoutNature
Micromarkers: miRNAs in cancer diagnosis and prognosis
2010
Many roads to maturity: microRNA biogenesis pathways and their regulation
2009 Standout
Opportunities in somatostatin research: biological, chemical and therapeutic aspects
2003
An efficient and sensitive method for preparing cDNA libraries from scarce biological samples
2014 StandoutNobel
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
2007 Standout
MicroRNA-223 Is Commonly Repressed in Hepatocellular Carcinoma and Potentiates Expression of Stathmin1
2008
MicroRNA biogenesis pathways in cancer
2015 Standout
Causes and consequences of microRNA dysregulation in cancer
2009 Standout
Role of miR-146a in human chondrocyte apoptosis in response to mechanical pressure injury in vitro
2014
MicroRNA expression and function in cancer
2006
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations
2008
Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis
2007 Standout
The hallmarks of cancer
2012 Standout
MicroRNAs in Human Cancer
2012
MicroRNA signatures in human cancers
2006 Standout
TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease
2016 Standout
Medical therapy for clinically non-functioning pituitary adenomas
2008
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Endogenous microRNA sponges: evidence and controversy
2016 Standout
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids
2010
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
2011 Standout
MicroRNA expression profile of bromocriptine-resistant prolactinomas
2014
Long noncoding RNAs: functional surprises from the RNA world
2009 Standout
Biogenesis of small RNAs in animals
2009 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Pathogenesis of pituitary tumors
2011
The role of MicroRNAs in human cancer
2016 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
2006
American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules
2010 Standout
Octreotide-Targeted Liposomes Loaded with CPT-11 Enhanced Cytotoxicity for the Treatment of Medullary Thyroid Carcinoma
2010
MicroRNAs in Cancer
2008
MicroRNAs in Development and Disease
2011
MicroRNAs in Cancer
2009 Standout
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy
2015 StandoutNobel
Guidelines for the management of thyroid cancer
2014 Standout
MicroRNA-Cancer Connection: The Beginning of a New Tale
2006
microRNA Functions
2007 Standout
Works of Daniela Piccin being referenced
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion
2007
Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line
2002
Somatostatin, but not Somatostatin Receptor Subtypes 2 and 5 Selective Agonists, Inhibits Calcitonin Secretion and Gene Expression in the Human Medullary Thyroid Carcinoma Cell Line, TT
2002
miR‐15a and miR‐16‐1 down‐regulation in pituitary adenomas
2005
Role of Complex Cyclin D1/Cdk4 in Somatostatin Subtype 2 Receptor-Mediated Inhibition of Cell Proliferation of a Medullary Thyroid Carcinoma Cell Line in Vitro
2006
Selective Activation of Somatostatin Receptor Subtypes Differentially Modulates Secretion and Viability in Human Medullary Thyroid Carcinoma Primary Cultures: Potential Clinical Perspectives
2006
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas
2006
Src Homology-2-Containing Protein Tyrosine Phosphatase-1 Restrains Cell Proliferation in Human Medullary Thyroid Carcinoma
2005
Evidence for Differential Effects of Selective Somatostatin Receptor Subtype Agonists on α-Subunit and Chromogranin A Secretion and on Cell Viability in Human Nonfunctioning Pituitary Adenomas in Vitro
2004